Authors: SHINEFIELD HR BLACK SB STAEHLE BO ADELMAN T ENSOR K NGAI A WHITE CJ BIRD SR MATTHEWS H KUTER BJ

Citation: Hr. Shinefield et al., SAFETY, TOLERABILITY AND IMMUNOGENICITY OF CONCOMITANT INJECTIONS IN SEPARATE LOCATIONS OF M-M-R(R)(II), VARIVAX(R) AND TETRAMUNE(R) IN HEALTHY-CHILDREN VS. CONCOMITANT INJECTIONS OF M-M-R(R)(II) AND TETRAMUNE(R) FOLLOWED 6 WEEKS LATER BY VARIVAX(R), The Pediatric infectious disease journal, 17(11), 1998, pp. 980-985

Authors: JOHNSON CE KUMAR ML WHITWELL JK STAEHLE BO ROME LP DINAKAR C HURNI W NALIN DR

Citation: Ce. Johnson et al., ANTIBODY PERSISTENCE AFTER PRIMARY MEASLES-MUMPS-RUBELLA VACCINE AND RESPONSE TO A 2ND DOSE GIVEN AT 4 TO 6 VS 11 TO 13 YEARS, The Pediatric infectious disease journal, 15(8), 1996, pp. 687-692

Authors: NGAI AL STAEHLE BO KUTER BJ CYANOVICH NM CHO I MATTHEWS H KELLER P ARVIN AM WATSON B WHITE CJ ANDERSON R ARBETER A ARVIN AM BLACK S BLOCK SL BLUMBERG D BRUNELL PA CHARTRAND SA CLEMENTS DA DENNEHY P KEYSERLING H NAUERT B REISINGER KS RENNELS MB REUMAN PD SHEHAB ZM STARR SE TUCKER R

Citation: Al. Ngai et al., SAFETY AND IMMUNOGENICITY OF ONE VS 2 INJECTIONS OF OKA MERCK VARICELLA VACCINE IN HEALTHY-CHILDREN/, The Pediatric infectious disease journal, 15(1), 1996, pp. 49-54

Authors: KUTER BJ NGAI A PATTERSON CM STAEHLE BO CHO IS MATTHEWS H PROVOST PJ WHITE CJ ARVIN A ARBETER A BALFOUR H BLUMBERG D BRUNELL P CHARTRAND S CHERRY J CLEMENTS D DAVIDSON M DEMMLER G DENNEHY P GERSHON A HARRIS A HAYDEN F JACOBSON J KESSLER H KUMAR M LAW B LEVIN M MAURER H OXMAN M REISINGER K SNYDMAN D SAVOIA M STARR S WHITLEY R WONG V YOGEV R

Citation: Bj. Kuter et al., SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF 2 REGIMENS OF OKA MERCK VARICELLA VACCINE (VARIVAX(R)) IN HEALTHY ADOLESCENTS AND ADULTS/, Vaccine, 13(11), 1995, pp. 967-972

Authors: SEAGER C MORIARITY J NGAI A STAEHLE BO NALIN DR

Citation: C. Seager et al., LOW INCIDENCE OF ADVERSE EXPERIENCES AFTER MEASLES OR MEASLES-RUBELLAMASS REVACCINATION AT A COLLEGE CAMPUS, Vaccine, 12(11), 1994, pp. 1018-1020